dr.villanueva
TL3 Physician · Manila, PH
Internal medicine. Interested in the comorbidity end — sleep apnoea, hepatic steatosis, renal function.
Joined 14 November 2024 · last posted 4d · groups: clinicians, regional-na
136Posts here
3Topics
0Solutions
4.5kLikes received
4.5kLikes given
24Badges
446Days visited
13kPosts read
Most-liked posts
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #72 · Sourcing › Vendor reports · 13 Oct 2025 · 32 likes Vendor documentation pages came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Gallbladder disease risk with rapid weight loss Replied, post #38 · Clinical › Comorbidities · 2 Dec 2024 · 31 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #8 · Compounds › Retatrutide · 18 Jun 2026 · 29 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
-
The headache that turns out to be dehydration Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 27 Oct 2025 · 29 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Checking someone else's arithmetic: a worked example thread Replied, post #30 · Practice › Reconstitution · 17 Mar 2025 · 29 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Moderation log format change Replied, post #56 · Meta › Announcements · 25 May 2026 · 28 likes I came in to disagree and I am leaving without a disagreement.
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Read the Guidelines | bronze | 15 Nov 2024 |
| Basic User | bronze | 17 Nov 2024 |
| First Reply | bronze | 19 Nov 2024 |
| First Topic | bronze | 21 Nov 2024 |
| First Quote | bronze | 29 Nov 2024 |
| First Link | bronze | 29 Nov 2024 |
| Welcome | bronze | 1 Dec 2024 |
| Sourced | bronze | 4 Dec 2024 |
| First Tag | bronze | 17 Dec 2024 |
| Generous | bronze | 27 Dec 2024 |
| Member | bronze | 6 Jan 2025 |
| Reader | bronze | 19 Jan 2025 |
| Regular | silver | 3 Mar 2025 |
| Consistently Generous | silver | 3 Mar 2025 |
| Editor | bronze | 6 Mar 2025 |
| Thank You | silver | 7 Apr 2025 |
| Nice Post | bronze | 3 May 2025 |
| Relentlessly Generous | gold | 17 May 2025 |
| Nice Topic | bronze | 9 Jun 2025 |
| Gives Back | gold | 15 Jun 2025 |
| Welcoming | silver | 5 Jul 2025 |
| Good Post | silver | 20 Aug 2025 |
| Well Sourced | silver | 20 Aug 2025 |
| Anniversary | silver | 14 Nov 2025 |